Viridian Therapeutics, Inc. VRDN

Set alert

28.49 USD -0.06 (-0.21%)

At closeNov 6, 2026, 7:52 PM EST

28.48 -0.01 -0.04%

After hours · Nov 6, 7:52 PM ET

27.86 Day range 29.46

13.30 52-week range 33.78

Held by insiders 0.17%

Held by institutions 126.07%

Float held by institutions 126.29%

Institutions 312

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	14.62%	16,604,740	473.07M	Jun 29, 2026
Blackrock Inc.	7.53%	8,551,488	243.63M	Jun 29, 2026
Bellevue Group AG	5.93%	6,731,909	191.79M	Jun 29, 2026
Paradigm Biocapital Advisors LP	5.92%	6,723,788	191.56M	Jun 29, 2026
Kynam Capital Management, LP	5.68%	6,453,877	183.87M	Jun 29, 2026
State Street Corporation	5.39%	6,124,976	174.50M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.94%	3,336,970	95.07M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.28%	2,590,081	73.79M	Sep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.20%	2,495,461	71.10M	Sep 29, 2026
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund	1.81%	2,058,130	58.64M	Sep 29, 2026
Fidelity Select Portfolios-Select Health Care Portfolio	1.32%	1,500,000	42.73M	Sep 29, 2026
T. Rowe Price Health Sciences Fund, Inc.	1.27%	1,447,742	41.25M	Jun 29, 2026

VRDN insiders
Insider	Relation	Latest transaction	Date	Shares held
BEETHAM THOMAS W	Chief Operating Officer	Conversion of Exercise of derivative security	Mar 2, 2026	13,361
FAIRMOUNT FUNDS MANAGEMENT LLC	Beneficial Owner of more than 10% of a Class of Security	Purchase	May 10, 2026	0
HARMON SETH	Chief Financial Officer	Conversion of Exercise of derivative security	Mar 2, 2026	7,790
MAHONEY STEPHEN F	Chief Executive Officer	Conversion of Exercise of derivative security	Mar 2, 2026	33,349
TOUSIGNANT JENNIFER	Officer	Sale	Aug 18, 2026	0
TRIPURANENI RADHIKA	Officer	Conversion of Exercise of derivative security	Aug 13, 2026	40,000

Held by funds